Back to Search
DEREK BAST DO
DO
Family Medicine Physician
NPI: 1437612272IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
02006451A(IN)
Education
OTHER
Class of 2019
Research & Publications (20)
Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice.
PMID 17267342·J Chemother·2006
4-observational
Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin.
PMID 15328095·Antimicrob Agents Chemother·2004
4-observational
Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance.
PMID 15190035·J Antimicrob Chemother·2004
8-other
Quinolone Resistance: Older Concepts and Newer Developments.
PMID 11177727·Curr Infect Dis Rep·2001
8-other
Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae.
PMID 11502541·Antimicrob Agents Chemother·2001
8-other
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.
PMID 11036021·Antimicrob Agents Chemother·2000
8-other
Regulation of sagA, siaA and scpC by SilCR, a putative signaling peptide of Streptococcus pyogenes.
PMID 19016875·FEMS Microbiol Lett·2008
7-preclinical
Antipneumococcal activity of ertapenem compared with gatifloxacin in a temperature-sensitive murine model of acute pneumonia.
PMID 17855183·J Chemother·2007
7-preclinical
Role for sagA and siaA in quorum sensing and iron regulation in Streptococcus pyogenes.
PMID 17635862·Infect Immun·2007
8-other
Capsule expression regulated by a two-component signal transduction system in Streptococcus iniae.
PMID 17537179·FEMS Immunol Med Microbiol·2007
8-other
The two-component system sivS/R regulates virulence in Streptococcus iniae.
PMID 17991014·FEMS Immunol Med Microbiol·2007
7-preclinical
Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.
PMID 17024792·J Chemother·2006
8-other
Identification of group A Streptococcus antigenic determinants upregulated in vivo.
PMID 16113323·Infect Immun·2005
7-preclinical
Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
PMID 15855546·Antimicrob Agents Chemother·2005
8-other
Is in vitro antibiotic combination more effective than single-drug therapy against anthrax?
PMID 15793105·Antimicrob Agents Chemother·2005
8-other
Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
PMID 15546106·Clin Infect Dis·2004
8-other
In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.
PMID 14688054·J Antimicrob Chemother·2004
8-other
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
PMID 14998982·J Antimicrob Chemother·2004
8-other
Selection of Bacillus anthracis isolates resistant to antibiotics.
PMID 15205405·J Antimicrob Chemother·2004
4-observational
Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.
PMID 12890324·Emerg Infect Dis·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 426 S ALABAMA ST STE 100
INDIANAPOLIS, IN 46225 - Phone
- (317) 528-2489
Quick Facts
- NPI
- 1437612272
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile